Concepedia

Erik Muser

EM

34

Publications

809

Citations

19

H-Index

2010

Active since

Affiliations

Janssen (United States)(Current)

Janssen Scientific Affairs (United States)

Group for Research in Decision Analysis

Analysis Group (United States)

STATinMED (United States)

Erik Muser is an author at Janssen (United States) specializing in public health, health policy, and medicine.

Top concepts

Publications per year

2010–2023

34

Publications

34

The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium

Amanda M. Johnson, Maria Barsky, Waseem Ahmed et al. · The American Journal of Gastroenterology · 2022 · 63 citations

Patterns of relapse and associated cost burden in schizophrenia patients receiving atypical antipsychotics

Marie‐Hélène Lafeuille, Jonathan Gravel, Patrick Lefèbvre et al. · Journal of Medical Economics · 2013 · 44 citations · Full text

Comparison of rehospitalization rates and associated costs among patients with schizophrenia receiving paliperidone palmitate or oral antipsychotics

Marie‐Hélène Lafeuille, Amanda Melina Grittner, Jonathan Fortier et al. · American Journal of Health-System Pharmacy · 2015 · 44 citations

Burden of Crohn’s disease in the United States: long-term healthcare and work-loss related costs

Ameur M. Manceur, Zhijie Ding, Erik Muser et al. · Journal of Medical Economics · 2020 · 41 citations · Full text

Predictors of medication nonadherence and hospitalization in Medicaid patients with bipolar I disorder given long-acting or oral antipsychotics

Kathleen Lang, Jonathan R. Korn, Erik Muser et al. · Journal of Medical Economics · 2011 · 40 citations

Rows per page

1–5 of 34